AgomAb Therapeutics

AgomAb Therapeutics

Foundation date

13/04/2017

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Proteins
• #Therapeutics - Antibodies

Therapeutic areas

• #Diseases of the blood and blood-forming organs - immune disorders
• #Endocrine - nutritional and metabolic diseases

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Our unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.